DLHCX
Price
$20.55
Change
-$0.18 (-0.87%)
Updated
Jun 13 closing price
Net Assets
658.18M
JNGLX
Price
$66.74
Change
-$0.42 (-0.63%)
Updated
Jun 13 closing price
Net Assets
4.35B
Interact to see
Advertisement

DLHCX vs JNGLX

Header iconDLHCX vs JNGLX Comparison
Open Charts DLHCX vs JNGLXBanner chart's image
Macquarie Healthcare C
Price$20.55
Change-$0.18 (-0.87%)
VolumeN/A
Net Assets658.18M
Janus Henderson Global Life Sciences D
Price$66.74
Change-$0.42 (-0.63%)
VolumeN/A
Net Assets4.35B
DLHCX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHCX vs. JNGLX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. DLHCX (658M). JNGLX pays higher dividends than DLHCX: JNGLX (0.36) vs DLHCX (0.00). DLHCX was incepted earlier than JNGLX: DLHCX (15 years) vs JNGLX (26 years). DLHCX (2.00) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. DLHCX (5.00). DLHCX has a lower initial minimum investment than JNGLX: DLHCX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -11.98 vs. DLHCX (-16.50). JNGLX return over 5 years is better than : 13.58 vs. DLHCX (-18.00).
DLHCXJNGLXDLHCX / JNGLX
Total Expense Ratio1.960.80245%
Annual Report Gross Expense Ratio2.000.80250%
Fund Existence15 years26 years-
Gain YTD-2.050-1.694121%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets658M4.35B15%
Annual Yield % from dividends0.000.36-
Returns for 1 year-16.50-11.98138%
Returns for 3 years-5.7820.71-28%
Returns for 5 years-18.0013.58-133%
Returns for 10 years-1.0312.35-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRDGX80.45-1.00
-1.23%
T. Rowe Price Dividend Growth
ETAGX51.91-0.77
-1.46%
Eventide Gilead A
ESCKX13.03-0.26
-1.95%
1290 Essex Small Cap Growth R
BRSHX12.95-0.27
-2.04%
MFS Blended Research Small Cap Eq C
EAGCX19.15-0.40
-2.05%
Eaton Vance Atlanta Capital Focused Gr C